Evidence map›Paper›PMID 31354896›Full record

ArticlePain research & management2019

Antiallodynic Effects of Cannabinoid Receptor 2 (CB

Wen S Sheng, Priyanka Chauhan, Shuxian Hu, Sujata Prasad, James R Lokensgard

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pain research & management, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Cannabinoid CBBritish journal of pharmacology · 2025
    Review
  2. Article
  3. The Impact of the CBMolecules (Basel, Switzerland) · 2024
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Wen S ShengNeurovirology Laboratory, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Priyanka ChauhanNeurovirology Laboratory, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Shuxian HuNeurovirology Laboratory, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Sujata PrasadNeurovirology Laboratory, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
James R LokensgardNeurovirology Laboratory, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.ORCID 0000-0002-1976-2035
University of Minnesota · US

Funding

Neuroimmune Approaches to Retrovirus Infection-induced Neuropathy via CB2RsR01DA039464 · NIDA · UNIVERSITY OF MINNESOTA · PI LOKENSGARD, JAMES R · 2016 to 2020
$1.9M
NIDA NIH HHS R01 DA039464
6 · The paper itself

Abstract

The most common neurological complication in patients receiving successful combination antiretroviral therapy (cART) is peripheral neuropathic pain. Data show that distal symmetric polyneuropathy (DSP) also develops along with murine acquired immunodeficiency syndrome (MAIDS) after infection with the LP-BM5 murine retrovirus mixture. Links between cannabinoid receptor 2 (CB

Indexed as

AnimalsCannabinoid Receptor AgonistsCannabinoidsDisease Models, AnimalHumansHyperalgesiaIndenesIndolesMaleMiceNeuralgiaPyrazolesRetroviridaeRetroviridae Infections1,1-dimethylbutyl-1-deoxy-Delta(9)-THCCannabinoid Receptor AgonistsCannabinoidsHU 308IndenesIndolesJHW 015N-(piperidin-1-yl)-1-(2,4-dichlorophenyl)-1,4-dihydro-6-methylindeno(1,2-c)pyrazole-3-carboxamidePyrazoles

Identifiers

PMID31354896
PMCPMC6637694
OpenAlexW2955041265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.